- Home
- BMY vs SPGI Comparison
BMY vs SPGI Comparison
Compare BMY & SPGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMY | SPGI |
|---|---|---|
| Founded | 1887 | 1860 |
| Country | United States | United States |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.5B | 124.6B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | BMY | SPGI |
|---|---|---|
| Price | $56.06 | $429.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 15 |
| Target Price | $61.73 | ★ $558.33 |
| AVG Volume (30 Days) | ★ 9.9M | 1.9M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 4.38% | 0.90% |
| EPS Growth | N/A | ★ 18.70 |
| EPS | N/A | ★ 4.69 |
| Revenue | N/A | ★ $6,063,000,000.00 |
| Revenue This Year | N/A | $9.66 |
| Revenue Next Year | N/A | $7.35 |
| P/E Ratio | ★ $17.26 | $92.43 |
| Revenue Growth | N/A | ★ 7.10 |
| 52 Week Low | $42.52 | $381.61 |
| 52 Week High | $62.89 | $579.05 |
Technical Indicators
Market Signals| Indicator | BMY | SPGI |
|---|---|---|
| Relative Strength Index (RSI) | 46.34 | 54.10 |
| Support Level | $53.98 | $404.19 |
| Resistance Level | $57.43 | $436.46 |
| Average True Range (ATR) | 1.27 | 10.49 |
| MACD | 0.04 | 1.54 |
| Stochastic Oscillator | 51.18 | 72.92 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About SPGI S&P Global Inc.
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include energy (formerly commodity insights, this segment includes Platts and other data), mobility (Carfax), and indexes. S&P plans to spin off mobility in 2026.